Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Elevated Health vs Eve

Elevated Health
Graded #283

Lower grade

vs+4.5
Eve
Graded #189

Higher grade

The verdict

Eve takes it — 66.3/100 to 61.8/100.

Eve grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eve is a women's-health-focused GLP-1 telehealth platform — distinctive positioning in a largely gender-neutral market — offering both compounded semaglutide and tirzepatide (including an oral sublingual…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEve +18
37
55
Dose & formulationEven
88
88
Clinical oversightEve +5
74
79
Labs & monitoringEven
52
52
FulfillmentEve +5
62
67
Contract termsElevated Health +20
61
41
Elevated Health · left barEve · right bar

The numbers

MetricElevated HealthEve
WeighScore61.8/10066.3/100
GradeCC
Scorecard rank#283#189
Semaglutide$296/mo (compounded)$195/mo (compounded)
Tirzepatide$359/mo (compounded)$195/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualYesYes
Elevated Health

Graded #283 · C

Strengths

  • $100 off first month
  • Oral semaglutide option
  • Competitive pricing — compounded semaglutide from $187/mo (12-month plan), tirzepatide from $235/mo

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity or address disclosed
  • State availability not disclosed
  • Shopify storefront — few clinical infrastructure signals
Eve

Graded #189 · C

Strengths

  • Genuinely women's-health-focused — fills a real gap among gender-neutral GLP-1 competitors
  • Both compounded and brand-name FDA-approved options (Wegovy/Ozempic/Mounjaro) on one platform — rare
  • LegitScript Certified with a verifiable ID
  • Publishes the FDA compounded-medication disclaimer
  • Oral sublingual semaglutide offered alongside injectable

Where it loses points

  • Full states-served list not disclosed publicly
  • 503A pharmacy partner not named, and 503A vs 503B status not specified
  • Named medical director / clinical leadership not disclosed
  • Corporate legal entity not disclosed
  • Governing law / arbitration venue not stated

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard